Key stats
About WISDOMTREE ISSUER ICAV - WISDOMTREE BIOREVOLUTION UCITS ETF
Home page
Inception date
Dec 3, 2021
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
Irish Life Investment Managers Ltd.
ISIN
IE000O8KMPM1
Functions as an open-end investment fund
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.91%
Health Technology83.85%
Process Industries6.28%
Health Services5.09%
Technology Services2.31%
Consumer Non-Durables1.51%
Electronic Technology0.88%
Bonds, Cash & Other0.09%
Cash0.09%
Stock breakdown by region
North America81.34%
Europe17.26%
Asia1.16%
Oceania0.25%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
WRNA invests in stocks. The fund's major sectors are Health Technology, with 83.85% stocks, and Process Industries, with 6.28% of the basket. The assets are mostly located in the North America region.
WRNA top holdings are Verve Therapeutics, Inc. and Intellia Therapeutics, Inc., occupying 5.26% and 3.08% of the portfolio correspondingly.
No, WRNA doesn't pay dividends to its holders.
WRNA shares are issued by WisdomTree, Inc. under the brand WisdomTree. The ETF was launched on Dec 3, 2021, and its management style is Passive.
WRNA expense ratio is 0.45% meaning you'd have to pay 0.45% of your investment to help manage the fund.
WRNA follows the WisdomTree BioRevolution Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
WRNA invests in stocks.